A phase 3 randomized, open-label (sponsor-blind), active controlled, parallel-group, multi-center, event driven study in non-dialysis subjects with anemia associated with chronic kidney disease to evaluate the safety and efficacy of daprodustat compared to darbepoetin alfa. Save

Date Added
December 13th, 2016
PRO Number
Pro00058563
Researcher
Ruth Campbell
Keywords
Kidney
Summary

The ASCEND-ND clinical research study is looking for
adults who have anemia caused by Chronic Kidney Disease. The study
doctors are testing an investigational medication to
see if it may safely boost production of EPO, thereby
increasing red blood cell production. (?Investigational?
means this medication isn?t yet approved for use by
the public.) This medication is a tablet that?s taken daily by mouth. Those who volunteer and qualify for this research study will receive all study-related medication and care at no cost.

Institution
MUSC
Recruitment Contact
Lori Spillers
843-792-8166
spillerl@musc.edu

Change_preferences

-- OR --

Create_login